A citation-based method for searching scientific literature

Beth N Peshkin, Scott Kelly, Rachel H Nusbaum, Morgan Similuk, Tiffani A DeMarco, Gillian W Hooker, Heiddis B Valdimarsdottir, Andrea D Forman, Jessica Rispoli Joines, Claire Davis, Shelley R McCormick, Wendy McKinnon, Kristi D Graves, Claudine Isaacs, Judy Garber, Marie Wood, Lina Jandorf, Marc D Schwartz. J Genet Couns 2016
Times Cited: 28







List of co-cited articles
154 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Validity of self-reported solar UVR exposure compared with objectively measured UVR exposure.
Karen Glanz, Peter Gies, David L O'Riordan, Tom Elliott, Eric Nehl, Frances McCarty, Erica Davis. Cancer Epidemiol Biomarkers Prev 2010
54
3

Common genetic risk for melanoma encourages preventive behavior change.
Lori Diseati, Laura B Scheinfeldt, Rachel S Kasper, Ruixue Zhaoyang, Neda Gharani, Tara J Schmidlen, Erynn S Gordon, Cecili K Sessions, Susan K Delaney, Joseph P Jarvis,[...]. J Pers Med 2015
20
5


Impact of direct-to-consumer genomic testing at long term follow-up.
Cinnamon S Bloss, Nathan E Wineinger, Burcu F Darst, Nicholas J Schork, Eric J Topol. J Med Genet 2013
100
3

Public health genomics and personalized prevention: lessons from the COGS project.
N Pashayan, A Hall, S Chowdhury, T Dent, P D P Pharoah, H Burton. J Intern Med 2013
19
5

Effectiveness of Australia's Get Healthy Information and Coaching Service®: translational research with population wide impact.
Blythe J O'Hara, Philayrath Phongsavan, Kamalesh Venugopal, Elizabeth G Eakin, Dianne Eggins, Hugh Caterson, Lesley King, Margaret Allman-Farinelli, Marion Haas, Adrian E Bauman. Prev Med 2012
54
3

Measures of sun exposure and sun protection practices for behavioral and epidemiologic research.
Karen Glanz, Amy L Yaroch, Monica Dancel, Mona Saraiya, Lori A Crane, David B Buller, Sharon Manne, David L O'Riordan, Carolyn J Heckman, Jennifer Hay,[...]. Arch Dermatol 2008
225
3

Impact of melanoma genetic test reporting on perceived control over melanoma prevention.
Lisa G Aspinwall, Tammy K Stump, Jennifer M Taber, Wendy Kohlmann, Samantha L Leaf, Sancy A Leachman. J Behav Med 2015
10
10

Family risk discussions after feedback on genetic risk of melanoma.
Jennifer L Hay, Mallorie Gordon, Yuelin Li. JAMA Dermatol 2015
3
33

MC1R genotypes and risk of melanoma before age 40 years: a population-based case-control-family study.
Anne E Cust, Chris Goumas, Elizabeth A Holland, Chantelle Agha-Hamilton, Joanne F Aitken, Bruce K Armstrong, Graham G Giles, Richard F Kefford, Helen Schmid, John L Hopper,[...]. Int J Cancer 2012
22
4

Mediation of improvements in sun protective and skin self-examination behaviours: results from the healthy text study.
Jannah Baker, Linda Finch, H Peter Soyer, Alison L Marshall, Peter Baade, Philippa Youl, Monika Janda. Psychooncology 2016
3
33

CONSORT 2010 Statement: Updated guidelines for reporting parallel group randomised trials.
Kenneth F Schulz, Douglas G Altman, David Moher. J Clin Epidemiol 2010
729
3

Quality of DNA extracted from saliva samples collected with the Oragene™ DNA self-collection kit.
Ana P Nunes, Isabel O Oliveira, Betânia R Santos, Cristini Millech, Liziane P Silva, David A González, Pedro C Hallal, Ana M B Menezes, Cora L Araújo, Fernando C Barros. BMC Med Res Methodol 2012
40
3

Participation rates in epidemiologic studies.
Sandro Galea, Melissa Tracy. Ann Epidemiol 2007
3

Cohort profile: the 45 and up study.
Emily Banks, Sally Redman, Louisa Jorm, Bruce Armstrong, Adrian Bauman, John Beard, Valerie Beral, Julie Byles, Stephen Corbett, Robert Cumming,[...]. Int J Epidemiol 2008
448
3

Effects of communicating DNA-based disease risk estimates on risk-reducing behaviours.
Theresa M Marteau, David P French, Simon J Griffin, A T Prevost, Stephen Sutton, Clare Watkinson, Sophie Attwood, Gareth J Hollands. Cochrane Database Syst Rev 2010
197
3


Estimating the economic costs of skin cancer in New South Wales, Australia.
Christopher M Doran, Rod Ling, Joshua Byrnes, Melanie Crane, Andrew Searles, Donna Perez, Anthony Shakeshaft. BMC Public Health 2015
25
4

Measuring exposure to solar ultraviolet radiation using a dosimetric technique: understanding participant compliance issues.
Jiandong Sun, Robyn M Lucas, Simone L Harrison, Ingrid van der Mei, David C Whiteman, Rebecca Mason, Madeleine Nowak, Alison M Brodie, Michael G Kimlin. Photochem Photobiol 2014
7
14

Genetic testing for melanoma risk: a prospective cohort study of uptake and outcomes among Australian families.
Nadine A Kasparian, Bettina Meiser, Phyllis N Butow, Judy M Simpson, Graham J Mann. Genet Med 2009
64
3

Skin examination behavior: the role of melanoma history, skin type, psychosocial factors, and region of residence in determining clinical and self-conducted skin examination.
Nadine A Kasparian, Richard Bränström, Yu-mei Chang, Paul Affleck, Lisa G Aspinwall, Aad Tibben, Esther Azizi, Orna Baron-Epel, Linda Battistuzzi, William Bruno,[...]. Arch Dermatol 2012
25
4

How much loss to follow-up is acceptable in long-term randomised trials and prospective studies?
Mary S Fewtrell, Kathy Kennedy, Atul Singhal, Richard M Martin, Andy Ness, Mijna Hadders-Algra, Berthold Koletzko, Alan Lucas. Arch Dis Child 2008
337
3

Attitudes and intentions in relation to skin checks for early signs of skin cancer.
Monika Janda, Philippa H Youl, John B Lowe, Mark Elwood, Ian T Ring, Joanne F Aitken. Prev Med 2004
46
3

Genome-wide meta-analysis identifies five new susceptibility loci for cutaneous malignant melanoma.
Matthew H Law, D Timothy Bishop, Jeffrey E Lee, Myriam Brossard, Nicholas G Martin, Eric K Moses, Fengju Song, Jennifer H Barrett, Rajiv Kumar, Douglas F Easton,[...]. Nat Genet 2015
137
3

Performance of a five-item mental health screening test.
D M Berwick, J M Murphy, P A Goldman, J E Ware, A J Barsky, M C Weinstein. Med Care 1991
923
3

Prevalence and costs of skin cancer treatment in the U.S., 2002-2006 and 2007-2011.
Gery P Guy, Steven R Machlin, Donatus U Ekwueme, K Robin Yabroff. Am J Prev Med 2015
344
3

Validity of covering-up sun-protection habits: Association of observations and self-report.
David L O'Riordan, Eric Nehl, Peter Gies, Lucja Bundy, Kristen Burgess, Erica Davis, Karen Glanz. J Am Acad Dermatol 2009
35
3

The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis.
Gareth J Hollands, David P French, Simon J Griffin, A Toby Prevost, Stephen Sutton, Sarah King, Theresa M Marteau. BMJ 2016
228
3

Recommendations for planning pilot studies in clinical and translational research.
Charity G Moore, Rickey E Carter, Paul J Nietert, Paul W Stewart. Clin Transl Sci 2011
191
3

Skin cancer concerns and genetic risk information-seeking in primary care.
J Hay, K A Kaphingst, R Baser, Y Li, S Hensley-Alford, C M McBride. Public Health Genomics 2012
21
4

Inherited predisposition to breast cancer among African American women.
Jane E Churpek, Tom Walsh, Yonglan Zheng, Zakiya Moton, Anne M Thornton, Ming K Lee, Silvia Casadei, Amanda Watts, Barbara Neistadt, Matthew M Churpek,[...]. Breast Cancer Res Treat 2015
82
3



What is it like to be in the minority? Ethnic and gender diversity in the genetic counseling profession.
K Cheri Schoonveld, Patricia McCarthy Veach, Bonnie S LeRoy. J Genet Couns 2007
22
4


Prevalence of pathogenic BRCA1 mutation carriers in 5 US racial/ethnic groups.
Esther M John, Alexander Miron, Gail Gong, Amanda I Phipps, Anna Felberg, Frederick P Li, Dee W West, Alice S Whittemore. JAMA 2007
219
3


Prevalence of BRCA mutations and founder effect in high-risk Hispanic families.
Jeffrey N Weitzel, Veronica Lagos, Kathleen R Blazer, Rebecca Nelson, Charité Ricker, Josef Herzog, Colleen McGuire, Susan Neuhausen. Cancer Epidemiol Biomarkers Prev 2005
121
3

A state-wide initiative to promote genetic testing in an underserved population.
Meghan L Underhill, Traci M Blonquist, Karleen Habin, Debra Lundquist, Kristen Shannon, Kathryn Robinson, Mary-Lou Woodford, Jean Boucher. Cancer Med 2017
6
16

Disparities in BRCA testing: when insurance coverage is not a barrier.
Windy Olaya, Pamela Esquivel, Jan H Wong, John W Morgan, Adam Freeberg, Sharmila Roy-Chowdhury, Sharon S Lum. Am J Surg 2009
34
3


Testing children for adult-onset genetic diseases.
E Charlisse F Caga-anan, Laurie Smith, Richard R Sharp, John D Lantos. Pediatrics 2012
12
8

Deleterious BRCA1/2 mutations in an urban population of Black women.
Filipa Lynce, Karen Lisa Smith, Julie Stein, Tiffani DeMarco, Yiru Wang, Hongkun Wang, Melissa Fries, Beth N Peshkin, Claudine Isaacs. Breast Cancer Res Treat 2015
11
9

Prevalence and type of BRCA mutations in Hispanics undergoing genetic cancer risk assessment in the southwestern United States: a report from the Clinical Cancer Genetics Community Research Network.
Jeffrey N Weitzel, Jessica Clague, Arelis Martir-Negron, Raquel Ogaz, Josef Herzog, Charité Ricker, Chelsy Jungbluth, Cheryl Cina, Paul Duncan, Gary Unzeitig,[...]. J Clin Oncol 2013
99
3

Participation of low-income women in genetic cancer risk assessment and BRCA 1/2 testing: the experience of a safety-net institution.
Ian K Komenaka, Jesse N Nodora, Lisa Madlensky, Lisa M Winton, Meredith A Heberer, Richard B Schwab, Jeffrey N Weitzel, Maria Elena Martinez. J Community Genet 2016
25
4

Coverage of clinical preventive services under the Affordable Care Act: from law to access.
Naomi Seiler, Mary-Beth Malcarney, Katie Horton, Scott Dafflitto. Public Health Rep 2014
14
7

Women with synchronous primary cancers of the endometrium and ovary: do they have Lynch syndrome?
Pamela T Soliman, Russell R Broaddus, Kathleen M Schmeler, Molly S Daniels, Delia Gonzalez, Brian M Slomovitz, David M Gershenson, Karen H Lu. J Clin Oncol 2005
69
3

Next-generation sequencing technologies and applications for human genetic history and forensics.
Eva C Berglund, Anna Kiialainen, Ann-Christine Syvänen. Investig Genet 2011
49
3

Long-term ovarian cancer survival associated with mutation in BRCA1 or BRCA2.
John R McLaughlin, Barry Rosen, Joel Moody, Tuya Pal, Isabel Fan, Patricia A Shaw, Harvey A Risch, Thomas A Sellers, Ping Sun, Steven A Narod. J Natl Cancer Inst 2013
92
3

Uptake of clinical genetic testing for ovarian cancer in Ontario: a population-based study.
Kelly A Metcalfe, Isabel Fan, John McLaughlin, Harvey A Risch, Barry Rosen, Joan Murphy, Linda Bradley, Susan Armel, Ping Sun, Steven A Narod. Gynecol Oncol 2009
45
3


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.